ReutersAstraZeneca sells rare cancer drug to Sanofi for up $300 millionReutersLONDON AstraZeneca, under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets. Sanofi's rare diseases unit Genzyme will pay AstraZeneca ...AstraZeneca sells Caprelsa rights to Sanofi unitMarketWatchSanofi to Buy Caprelsa Drug from AstraZeneca for $300 MillionBloombergAstraZeneca Strikes Deal With Genzyme To Sell Caprelsa GloballyLondon South EastStock Market Wireall 8 news articles »
AstraZeneca sells rare cancer drug to Sanofi for up $300 million
Rating: 4.5
Diposkan Oleh: Unknown
